Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
284
-
Total 13F shares, excl. options
-
83,034,095
-
Shares change
-
+2,881,619
-
Total reported value, excl. options
-
$6,308,626,498
-
Value change
-
+$222,918,594
-
Put/Call ratio
-
1.52%
-
Number of buys
-
115
-
Number of sells
-
-136
-
Price
-
$75.98
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q3 2022
351 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q3 2022.
NovoCure Ltd - Common Stock (NVCR) has 284 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83,034,095 shares
of 111,111,111 outstanding shares and own 74.73% of the company stock.
Largest 10 shareholders include FMR LLC (15,440,108 shares), Capital World Investors (12,788,239 shares), BAILLIE GIFFORD & CO (8,914,191 shares), VANGUARD GROUP INC (8,238,835 shares), Capital International Investors (7,916,635 shares), BlackRock Inc. (7,379,945 shares), STATE STREET CORP (2,624,838 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,371,986 shares), Deep Track Capital, LP (1,293,761 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,281,562 shares).
This table shows the top 284 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.